The ExactVu micro-ultrasound platform provides the most practical solution as a new tool for urologists to perform targeted biopsies within a standard urological workflow.
300%
Improvement
The world's first
29MHz
micro-ultrasound system
The ExactVu micro-ultrasound platform provides the most practical solution as a new tool for urologists to perform targeted biopsies within a standard urological workflow.
Fast ~ 15 minutes for total procedure
Urologist-controlled procedure
Targeted Biopsies in real-time
Single Procedure in 1 patient visit
Differentiate Suspicious Regions
assisted by the PRI-MUS
evidence-based protocol
Target in real-time Visualize suspicious regions
and target biopsies with micro-ultrasound
The ExactVu micro-ultrasound platform provides the most practical solution as a new
tool for urologists to perform targeted biopsies within a standard urological workflow.
The ExactVu system is a complete urological platform as it is the world’s first system supporting
both high-resolution and conventional transducers. The 29 MHz transducer
is for targeted and systematic biopsy procedures and conventional resolution
transducers are for abdominal, testicular and large prostate imaging procedures.
The ExactVu micro-ultrasound platform provides the most practical solution as a new tool for urologists to perform targeted biopsies within a standard urological workflow.
Video loop showing the detection, visualization and targeting of a guided prostate biopsy using the ExactVu micro-ultrasound at a small Gleason 8 lesion. The small hypoechoic lesion is .49 cm x .61 cm (.19” x .24”) in size. Biopsy was verified by clinical pathology.
ExactVu™, Exact Imaging™, PRI-MUS™, FusionVu™, Cognitive Assist™ and ExactVu Micro Doppler™ are trademarks of Exact Imaging.
ExactVu™ micro-ultrasound system is available for sale in the European Union (CE Mark), the United States (FDA 510(k) clearance), and in Canada (Health Canada license).
Fast 
Urologist-controlled 
Targeted Biopsies 
Single Procedure 
Differentiate 
Target in real-time 
